Hepatitis A/B vaccine: patient group direction template
Patient group direction (PGD) template to support the provision of hepatitis A and B (HepA/B) vaccine to individuals requiring protection against hepatitis A and hepatitis B.
- From:
-
UK Health Security Agency
PublishedPublished:- 13 November 2017
- Last
updatedupdated: -
16- 30
OctoberSeptember2023 - 30
Applies to England
Documents
HepA/B vaccine PGD
Ref: UKHSA gateway number GOV-15400
MS Word Document, 160241 KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
The HepA/B vaccine patient group direction (PGD) supports the provision of HepA/B vaccine to individuals aged one year and over who require immunisation against hepatitis A and B virus.
The HepA/B vaccine PGD version 4.00 5.0 is valid from 31 October 20232026 to 31 October 2026.2029.
Practitioners must not use these PGD templates until they have been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.
These PGD templates should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.
Updates to this page
Published 13 November 2017
Last updated 1630 OctoberSeptember 2023
+ show2026
—
Show all updates
-
Sign up for emails or print this page
HepA/B vaccine PGD
Ref: UKHSA gateway number GOV-15400
MS Word Document, 160241 KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
The HepA/B vaccine patient group direction (PGD) supports the provision of HepA/B vaccine to individuals aged one year and over who require immunisation against hepatitis A and B virus.
The HepA/B vaccine PGD version 4.00 5.0 is valid from 31 October 20232026 to 31 October 2026.2029.
Practitioners must not use these PGD templates until they have been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.
These PGD templates should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.
Updates to this page
Published 13 November 2017
Last updated 1630 OctoberSeptember 2023
+ show2026
—
Show all updates
-
Sign up for emails or print this page
Details
The HepA/B vaccine patient group direction (PGD) supports the provision of HepA/B vaccine to individuals aged one year and over who require immunisation against hepatitis A and B virus.
The HepA/B vaccine PGD version 4.00 5.0 is valid from 31 October 20232026 to 31 October 2026.2029.
Practitioners must not use these PGD templates until they have been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.
These PGD templates should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.